Steroid hormone receptors act promarily in the nucleus

Steroid hormones are lipophilic → can diffuse directly through the plasma membrane into the cytosol.
Inactive state (no hormone present):
- Cytosolic receptor is tightly bound to a heat-shock protein (HSP).
- HSP keeps the receptor sequestered in the cytosol and unable to affect DNA.
Hormone binding sequence:
- Incoming steroid has higher affinity for the receptor than the HSP does.
- Steroid displaces the HSP → forms a hormone–receptor complex.
- Complex translocates into the nucleus.
- Binds to specific DNA motifs called glucocorticoid response elements (GREs).
- Directly regulates transcription of target genes (↑ or ↓ mRNA synthesis).
Key points about this mechanism:
- Considered “simpler” than membrane-bound signaling: fewer intermediates, direct genomic action.
- Each activated receptor–steroid complex typically modulates one gene at a time before moving on to another.
- Cellular effect is limited by:
- Number of receptor molecules.
- Transcription/translation speed of each target gene.
- Absence of an intrinsic amplification cascade.

Ligand binds to a membrane receptor (e.g., GPCR).
Triggers multistep cascade:
- $\text{Receptor} \rightarrow G\text{ protein} \rightarrow \text{Adenylyl cyclase} \rightarrow cAMP$
- $\text{cAMP} \rightarrow \text{Protein Kinase A (PKA)} \rightarrow \text{Phosphorylated targets}$
Amplification:
- One ligand–receptor event can generate hundreds of cAMP molecules.
- Each cAMP activates multiple PKA subunits.
- Each PKA phosphorylates many substrate proteins.
Leads to rapid and massive cellular responses (seconds–minutes).
Downstream effects can still include changes in transcription (via CREB, etc.), but with a magnified initial push.

Classroom poll scenario: Many students instinctively choose steroid hormones.
Instructor’s answer: Signal-transduction pathways produce the greater effect due to amplification.
Rationale:
- Steroid action: $1$ hormone → $1$ receptor → $1$ gene (serial).
- Membrane signaling: $1$ ligand → $\sim100$ cAMP → $\sim100$ PKA → $\text{hundreds–thousands}$ phosphorylated proteins (parallel).
- Amplified cascade achieves broader, faster, and often stronger modulation of cellular physiology.

Drug design:
- Signal-pathway agonists/antagonists can leverage amplification → small doses, large effects.
- Steroid-like drugs may produce slower but longer-lasting genomic effects; careful dosing needed to avoid off-target gene regulation.
Physiological timing:
- Membrane pathways handle acute responses (fight-or-flight, metabolic surges).
- Steroid hormones manage longer-term adaptations (development, stress recovery, circadian rhythms).
Side-effect profiles:
- Amplified cascades risk hyper-responsiveness or desensitization (e.g., GPCR down-regulation).
- Steroid treatments risk widespread gene-expression changes → immunosuppression, metabolic shifts.

[ ] Know the role of heat-shock proteins in keeping steroid receptors inactive.
[ ] Be able to trace the steroid hormone path: diffusion → receptor binding → nuclear entry → GRE binding → transcription.
[ ] Memorize the core amplification logic of membrane signaling (GPCR → cAMP → PKA).
[ ] Understand why amplification confers greater overall cellular impact than direct genomic action.
[ ] Associate timescale with each mechanism: rapid (seconds–minutes) vs slower (hours–days).

This slide concluded the current chapter.
Upcoming chapter is described as the instructor’s “least favorite,” but commitment to teaching it remains.
Encouragement to stay engaged and continue studying the signaling material.